Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL394P encodes a pseudogene derived from the RNA, 7SL, cytoplasmic (the non-coding RNA component of the signal recognition particle, or SRP), but does not produce a functional molecule. The parent gene, 7SL RNA, is essential for recognizing signal peptides in newly synthesized proteins and targeting them to the endoplasmic reticulum by the SRP complex; this function is not present in the pseudogene. RN7SL pseudogenes, including RN7SL394P, arise from the reverse transcription and integration of 7SL RNA sequences into the genome; they are typically nonfunctional, may be truncated, and have no known roles as drug targets or in human disease[2][3][5]. In summary, RN7SL394P is a non-functional pseudogene corresponding to 7SL RNA and is not a therapeutic target or functional receptor, enzyme, or transporter[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 394, pseudogene (RN7SL394P).